In hematological tumorigenesis, two conventional tumorigenesis-related signaling pathways, the oncogenic MYC pathway and the onco-suppressive p53/p21 pathway, are influenced by PCBPs, making it plausible that the same gene can be oncogenic and tumor-suppressive simultaneously. The gene discussed is TP53; the disease is neoplasm.